Omega-3 fatty acids supplementation improve nutritional status and inflammatory response in patients with lung cancer: a randomized clinical trial
How to cite
Huo, Qianlun. 2021. "Omega-3 fatty acids supplementation improve nutritional status and inflammatory response in patients with lung cancer: a randomized clinical trial." AEA RCT Registry. AEARCTR-0007165. https://doi.org/10.1257/rct.7165-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Background & aims: Clinical studies have reported positive results with omega-3 supplements in oncologic patients. The aim of this study was to evaluate the efficacy of Omega-3 fatty acids supplementation in improving nutritional status and inflammatory markers of patients with lung cancer.
Methods: In a randomized double blind parallel design trial, sixty patients with lung cancer at nutritional status risk based on Nutrition Risk Screening 2002 were randomized to be allocated to two study groups, receiving omega 3 fatty acids supplement (EPA 1.6 g and DHA 0.8 g) or placebo for 12 weeks. Anthropometric measurements (weight, BMI, upper-arm circumference, and triceps skinfold thickness), nutritional based laboratory indices (hemoglobin, albumin, triglyceride, cholesterol), and inflammatory markers (CRP, TNF alpha, and IL-6) were measured before and after the intervention as study outcomes.
Intervention
Omega-3 fatty acids supplementation gel capsules (EPA 1.6 g and DHA 0.8 g), or placebo gel capsules (sunflower oil) with similar appearance (supplied by Sinadaro, China) were provided to the patients for 12 weeks of intervention. The patients’ compliance was evaluated by a form marked on each day of taking capsules. Patients with more than 3 lost dose was excluded from the analysis.
Experimental design
The study was designed as a double-blinded placebo-controlled randomized clinical trial including two-arms with parallel design. No change was made in methods after trial commencement.
Design details
Cited by
No citation data available for this registration yet.